Pharmacokinetic Study in Healthy Males
NCT02312232
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Parkinson's Disease
Interventions
DRUG:
levodopa, carbidopa, ODM-104
Sponsor
Orion Corporation, Orion Pharma